Keith C. Kummerfeld - Dec 15, 2023 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role: Senior Vice President of Finance (Principal Accounting Officer)
Signature: /s/ Ilan Katz, attorney-in-fact
Stock symbol: ARCT
Transactions as of: Dec 15, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/19/2023, 08:00 PM
Previous filing: Jul 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARCT	Employee Stock Option (right to buy)	Award	$0	+30K		$0.00	30K	Dec 15, 2023	Common Stock	30K	$28.88	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
F2	The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.

Remarks:

Senior Vice President of Finance (Principal Accounting Officer)